Harmony Biosciences Reports Third Quarter 2021 Financial Results and Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
Harmony Biosciences (HRMY) Files Mixed Shelf
November 9, 2021 4:04 PM ESTHarmony Biosciences (NASDAQ: HRMY) files mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Units
Harmony Biosciences (HRMY) Tops Q3 EPS by 22c
November 9, 2021 7:32 AM ESTHarmony Biosciences (NASDAQ: HRMY) reported Q3 EPS of $0.51, $0.22 better than the analyst estimate of $0.29. Revenue for the quarter came in at $80.7 million versus the consensus estimate of $80.92 million.
For earnings history and earnings-related data on Harmony Biosciences (HRMY) click here.
... More